Evidence map›Paper›PMID 40052066›Full record

ArticleOncology letters2025

[

Laurèl Rauschenbach, Felix M Gerach, Christoph Berliner, Tobias Blau, Sied Kebir, Celia Dobersalske, Cornelius Deuschl, Ulrich Sure, Ken Herrmann, Philipp Dammann

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Laurèl RauschenbachDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, D-45147 Essen, Germany.
Felix M GerachDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, D-45147 Essen, Germany.
Christoph BerlinerDepartment of Nuclear Medicine, University Hospital Essen, D-45147 Essen, Germany.
Tobias BlauInstitute of Neuropathology, University Hospital Essen, D-45147 Essen, Germany.
Sied KebirDKFZ Division of Translational Neurooncology at The West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, A Partnership Between DKFZ and University Hospital Essen, University Duisburg-Essen, D-45147 Essen, Germany.
Celia DobersalskeDKFZ Division of Translational Neurooncology at The West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, A Partnership Between DKFZ and University Hospital Essen, University Duisburg-Essen, D-45147 Essen, Germany.
Cornelius DeuschlInstitute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, D-45147 Essen, Germany.
Ulrich SureDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, D-45147 Essen, Germany.
Ken HerrmannDepartment of Nuclear Medicine, University Hospital Essen, D-45147 Essen, Germany.
Philipp DammannDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, D-45147 Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[

Indexed as

DOTAglioblastomagliomapositron emission tomographysomatostatin receptor

Identifiers

PMID40052066
PMCPMC11883336

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.